The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease

Archives of Gerontology and Geriatrics

Volumn 49, Issue 2, 2009, Pages 255-259

  Lee, Seung Jae ^a   Kim, Joong Seok ^a   Lee, Kwang Soo ^a   An, Jae Young ^a   Kim, Woojun ^a   Kim, Yeong In ^a   Kim, Bum Soo ^a   Jung, So Lyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Leukoaraiosis severity; Motor handicap; Parkinson's disease; Phenotypes of PD

Indexed keywords

AGED; ARTICLE; BALANCE DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GAIT DISORDER; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SYMPTOMATOLOGY; TREMOR;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

PARKINSONIA;

EID: 67649819421     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.09.005     Document Type: Article

References (33)

1. Acharya H.J., Bouchard T.P., Emery D.J., and Camicioli R.M. Axial signs and magnetic resonance imaging correlates in Parkinson's disease. Can. J. Neurol. Sci. 34 (2007) 56-61
2. Agid Y., Graybiel A.M., Ruberg M., Hirsch E., Blin J., Dubois B., and Javoy-Agid F. The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?. Adv. Neurol. 53 (1990) 83-100
3. Awad I.A., Masaryk T., and Magdinec M. Pathogenesis of subcortical hyperintense lesions on MRI of the brain. Observations in patients undergoing controlled ICA occlusion. Stroke 24 (1993) 1339-1346
4. Baloh R.W., and Vinters H.V. White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation. Arch. Neurol. 52 (1995) 975-981
5. Baloh R.W., Yue Q., Socotch T.M., and Jacobson K.M. White matter lesions and disequilibrium in older people. I. Case-control comparison. Arch. Neurol. 52 (1995) 970-974
6. Barber R., Scheltens P., Gholkar A., Ballard C., McKeith I., Ince P., Perry R., and O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J. Neurol. Neurosurg. Psychiatry 67 (1999) 66-72
7. Beyer M.K., Aarsland D., Greve O.J., and Larsen J.P. Visual rating of white matter hyperintensities in Parkinson's disease. Mov. Disord. 21 (2006) 223-229
8. Bloem B.R., Beckley D.J., van Dijk J.G., Zwinderman A.H., Remler M.P., and Roos R.A. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease. Mov. Disord. 11 (1996) 509-521
9. Bonnet A.M., Loria Y., Saint-Hilaire M.H., Lhermitte F., and Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesion?. Neurology 37 (1987) 1539-1542
10. Braak H., and Braak E. Pathoanatomy of Parkinson's disease. J. Neurol. 247 (2000) SII3-SII10
11. Capizzano A.A., Acion L., Bekinschtein T., Furman M., Gomila H., Martinez A., Mizrahi R., and Starkstein S.E. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75 (2004) 822-827
12. Derejko M., Slawek J., Wieczorek D., Dubaniewicz M., and Lass P. The influence of vascular risk factors and white matter hyperintensities on the degree of motor impairment in Parkinson's disease. Neurol. Neurochir. Pol. 40 (2006) 276-283
13. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
14. Hughes A.J., Daniel S.E., Blankson S., and Lees A.J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50 (1993) 140-148
15. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., Huber S., Koller W., Olanow C., and Shoulson I. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40 (1990) 1529-1534
16. Jorgensen H.S., Nakayama H., Raaschou H.O., and Olsen T.S. Leukoaraiosis in stroke patients: the Copenhagen Stroke Study. Stroke 26 (1995) 588-592
17. 123I] metaiodobenzyl-guanidine scintigraphy for vascular Parkinsonism. Mov. Disord. 21 (2006) 1990-1994
18. Liao D., Cooper L., Cai J., Toole J.F., Bryan N.R., Hutchinson R.G., and Tyroler H.A. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 27 (1996) 2262-2270
19. Miyazawa N., Satoh T., Hashizume K., and Fukamachi A. Xenon contrast CT-CBF measurements in high-intensity foci on T2-weighted MR images in centrum semiovale of asymptomatic individuals. Stroke 28 (1997) 984-987
20. O'Sullivan M., Lythgoe D.J., Pereira A.C., Summers P.E., Jarosz J.M., Williams S.C., and Markus H.S. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59 (2002) 321-326
21. Papapetropoulos S., Ellul J., Argyriou A.A., Talelli P., Chroni E., and Papapetropoulos T. The effect of vascular disease on late onset Parkinson's disease. Eur. J. Neurol. 11 (2004) 231-235
22. Piccini P., Pavese N., Canapicchi R., Paoli C., Del Dotto P., Puglioli M., Rossi G., and Bonuccelli U. White matter hyperintensities in Parkinson's disease. Arch. Neurol. 52 (1995) 191-194
23. Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?. Mov. Disord. 18 (2003) S43-S51
24. Raiha I., Tarvonen S., Kurki T., Rajala T., and Sourander L. Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol. Scand. 87 (1993) 286-289
25. Rektor I., Rektorova I., and Kubova D. Vascular parkinsonism-an update. J. Neurol. Sci. 248 (2006) 185-191
26. Sibon I., Fenelon G., Quinn N.P., and Tison F. Vascular parkinsonism. J. Neurol. 251 (2004) 513-524
27. Sohn Y.H., and Kim J.S. The influence of white matter hyperintensities on the clinical features of Parkinson's disease. Yonsei Med. J. 39 (1998) 50-55
28. Weinrich M., Koch K., Garcia F., and Angel R.W. Axial versus distal motor impairment in Parkinson's disease. Neurology 38 (1988) 540-545
29. Winikates J., and Jankovic J. Clinical correlates of vascular parkinsonism. Arch. Neurol. 56 (1999) 98-102
30. Wiszniewska M., Devuyst G., Bogousslavsky J., Ghika J., and van Melle G. What is the significance of leukoaraiosis in patients with acute ischemic stroke?. Arch. Neurol. 57 (2000) 925-926
31. Wong T.Y., Klein R., Sharrett A.R., Couper D.J., Klein B.E., Liao D.P., Hubbard L.D., and Mosley T.H. ARIC investigators, Atherosclerosis Risk in Communities Study, 2002. Cerebral white matter lesions, retinopathy, and incident clinical stroke. J. Am. Med. Assoc. 288 (2002) 67-74
32. Ylikoski A., Erkinjuntti T., Raininko R., Sarna S., Sulkava R., and Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Stroke 26 (1995) 1171-1177
33. Zijlmans J.C., Daniel S.E., Hughes A.J., Revesz T., and Lees A.J. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov. Disord. 19 (2004) 630-640